Total body itch with no clear cause puzzles patients, physicians
Sewickley, Pa. — There are few things more aggravating than an itch you can't scratch — but for geriatric patients that aggravation can be almost unbearable, as the elderly are often susceptible to a total body itch that has no apparent cause, and therefore no apparent solution. There are a number of potential causes that dermatologists should consider as they try to relieve their patient's itch, an expert says.
"Xerosis is the cause of the itch. A barrier defect occurs in the stratum corneum, so there's increased trans-epidermal water loss. The geriatric skin has more difficulty retaining moisture," says Dr. Bikowski, clinical assistant professor of dermatology, Ohio State University, Columbus, Ohio. "To make the diagnosis, the best place to look for dry skin is in the lateral aspect of the leg."
Dr. Bikowski says dry skin should always be treated, regardless of whether it is the primary cause of the itching, because it can be an aggravating factor. He recommends a ceramide-containing skin lotion, such as CeraVe (Coria) or Cetaphil Restoraderm (Galderma).
The second potential cause of itching that should be investigated is infestation, Dr. Bikowski says.
"Geriatric patients, especially those in nursing homes, may be susceptible to a higher incidence of scabies than the general population," Dr. Bikowski says. "(Physicians) always have to look for scabies, which may present as minute burrows in the palms of the hand, the wrists and the other usual locations. In the nursing home population, scabies may also present with lesions on the trunk as well as the scalp. The lesions are usually from 4 to 6 centimeter papules."
The third potential cause of total body itch that should be considered, Dr. Bikowski says, is a drug reaction.
"The difficulty is that the geriatric patient is frequently on multiple medications," he says. "Multiple drugs can certainly cause total body itch without primary rash, and it can often be difficult to elucidate which drug is the cause."
That difficulty can be exacerbated by an elderly patient's inability to provide a thorough medical history due to memory loss. In addition, non-prescription medications such as vitamins, laxatives and eye drops must be taken into account.
Treating an itch caused by medication may be difficult due to the therapeutic risk or benefit of changing or eliminating drugs.
MORE ARTICLES IN THIS ISSUE
Drugmaker Allergan recently agreed to pay $600 million to resolve federal charges that the company improperly marketed Botox (onabotulinumtoxinA) for off-label use. On Call wondered whether dermatologists think that this increased effort in enforcing off-label marketing rules is a good pursuit for the government. Would derms rather they never be allowed to hear about potentially beneficial off-label uses from drug reps?
Melanocytic nevi always have the potential to change in size, shape and color regardless of when they first appear in the skin, or the age of the patient. A recent study shows that though some nevi demonstrate dynamic change throughout a pregnancy, there does not appear to be an increased risk of malignant transformation of these nevi, nor is there an association between changing nevi and melanoma.
Rising melanoma rates among patients of color in portions of the country indicate that dermatologists must tailor specific sun-safety messages for these populations, experts say.
Lenore S. Kakita, M.D., learned about perseverence, acceptance, determination and strength during an unlikely time. She was a United States-born Japanese toddler when the fear of "Yellow Peril" gripped the country during World War II. She spent five of the first six years of her life in U.S. relocation camps. Her father, Hajime Uyeyama, M.D., a family practitioner born in Berkeley, Calif., was forced to close his Oakland practice, and he and his family were interned at camps in California, then in Colorado.
Dr. Buttox travels to Europe to learn about a new botulinum toxin that is popular there. He understands he can't use the product in his office without FDA approval, but his marketing department gets him to discuss the product with the national press. Does the FDA have jurisdiction over Dr. Buttox in this instance, and if so, to what extent?